ArticleThe oncologist2026

Dynamic therapeutic response to osimertinib and immunotherapy in an EGFR L747S and L858R co-mutant NSCLC.

Yuqing Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.